unblinded dexcom g6 (Dexcom Inc)

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Dexcom Inc unblinded dexcom g6

Study design overview. Participants were first screened, randomized, and trained in CGM use. Subjects were then assigned to begin with either a <t>10-day</t> <t>unblinded</t> CGM (Dexcom <t>G6)</t> or 10-day blinded CGM (Dexcom G6 Pro) period. Each monitoring phase was followed by completion of the Hypoglycemia Fear Survey-II (HFS-II), an event diary, and training (if applicable) with a new CGM device. All participants crossed over to the alternate CGM modality for another 10-day period. The study concluded with repeated HFS-II assessments, event diary entries, and CGM data download. Blinded CGM data (Dexcom G6 Pro) was used for all outcome analyses to ensure consistency.

Unblinded Dexcom G6, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexcom+g6/dexcom+g6+pro+%E2%80%A2/pmc12371835-104-36-37
Average 86 stars, based on 1 article reviews

unblinded dexcom g6 - by Bioz Stars, 2026-11

86/100 stars

Images

1) Product Images from "Continuous Glucose Monitoring in Patients With Postbariatric Hypoglycemia: Effect on Hypoglycemia and Quality of Life"

Article Title: Continuous Glucose Monitoring in Patients With Postbariatric Hypoglycemia: Effect on Hypoglycemia and Quality of Life

Journal: Journal of the Endocrine Society

doi: 10.1210/jendso/bvaf106

Study design overview. Participants were first screened, randomized, and trained in CGM use. Subjects were then assigned to begin with either a 10-day unblinded CGM (Dexcom G6) or 10-day blinded CGM (Dexcom G6 Pro) period. Each monitoring phase was followed by completion of the Hypoglycemia Fear Survey-II (HFS-II), an event diary, and training (if applicable) with a new CGM device. All participants crossed over to the alternate CGM modality for another 10-day period. The study concluded with repeated HFS-II assessments, event diary entries, and CGM data download. Blinded CGM data (Dexcom G6 Pro) was used for all outcome analyses to ensure consistency.

Figure Legend Snippet: Study design overview. Participants were first screened, randomized, and trained in CGM use. Subjects were then assigned to begin with either a 10-day unblinded CGM (Dexcom G6) or 10-day blinded CGM (Dexcom G6 Pro) period. Each monitoring phase was followed by completion of the Hypoglycemia Fear Survey-II (HFS-II), an event diary, and training (if applicable) with a new CGM device. All participants crossed over to the alternate CGM modality for another 10-day period. The study concluded with repeated HFS-II assessments, event diary entries, and CGM data download. Blinded CGM data (Dexcom G6 Pro) was used for all outcome analyses to ensure consistency.

Techniques Used:

Biomarker Discovery:

Article Title: Continuous Glucose Monitoring for Pregnant Patients With Gestational Diabetes and Type 2 Diabetes
Article Snippet: Glucose monitoring is arguably one of the most important components of diabetes management in pregnancy.. In this review, the application of continuous glucose monitoring (CGM) in managing diabetes during pregnancy is explored with a focus on gestational diabetes mellitus (GDM) and type 2 diabetes (T2D).. It highlights the expanding applications of CGM technology, starting with evidence from the landmark CONCEPTT trial.

Clinical Proteomics:

other:

Article Title: Association between Continuous Glucose Monitoring and Risk of Acute Diabetes-Related Complications in Pediatric Type 1 Diabetes Mellitus: A Nationwide Cohort Study.
Article Snippet: We previously reported that high CGM utilization was associated with increased time in range and decreased time above and below range among Dexcom G6 users in South Korea [11].

Article Title: Imputation of Missing Continuous Glucose Monitor Data.
Article Snippet: At these visits, a blinded Dexcom G6 Pro CGM (Dexcom, Inc, San Diego, California) is inserted for ten days of wear as specified in the GO MOMs protocol.1 The Dexcom G6 Pro measures interstitial glucose every 5 minutes for up to 288 measurements over a 24-hour period.

Article Title: A Manual of Procedures for the Generation of the AI-Ready and Exploratory Atlas for Diabetes Insights (AI-READI) Database
Article Snippet: To export data collected by the Dexcom G6 PRO sensor, you will need the reader and the transmitter.

Review